Ignite Creation Date:
2024-05-06 @ 3:47 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04752215
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-19
First Post:
2021-02-11
Brief Title:
A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell Surface
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Colorectal Neoplasms Carcinoma Non-Small-Cell Lung Pancreatic Neoplasms Carcinoma Hepatocellular Head and Neck Neoplasms Gastrointestinal Neoplasms |
Keywords: